alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2018422EN.01000401.xml

| 22.11.2018 | EN | Official Journal of the European Union | C 422/4 |
| --- | --- | --- | --- |

22.11.2018

EN

Official Journal of the European Union

C 422/4

---

Non-opposition to a notified concentration

(Case M.8984 — HG/Vista/Allocate)

(Text with EEA relevance)

(2018/C 422/02)

On 22 August 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8984. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8984. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Natasha DELIMA, Petitioner v. MASSACHUSETTS, et al.

No. 19-6007

Supreme Court of the United States.

November 18, 2019

Petition for writ of certiorari to the United States Court of Appeals for the First Circuit denied.
10f-3 REPORT

SALOMON BROTHERS CAPITAL FUND
April 1, 2000 through June 30, 2000

                       Trade                                   % of
Issuer                 Date    Selling Dealer    Amount  Price Issue(1)

Uticom                  4/5/00 Lehman Brothers  $32,500 $13.00 0.11A
Centillium
 Communications        5/23/00 First Boston       5,700  19.00 0.01B
Charles River          6/23/00 DLJ               40,000  16.00 0.04C
Manufacturers Services 6/23/00 DLJ               40,000  16.00 0.04D
Capstone Turbine       6/29/00 Goldman Sachs     80,000  16.00 0.10E
Genuity                6/29/00 Morgan Stanley 2,063,600  11.00 0.15F
Mobile Telesystem      6/30/00 Deutsche Banc     43,000  22.00 0.03G
Netease                6/30/00 Merrill Lynch     23,250  16.00 0.06H

(1) Represents purchases by all affiliated funds; may not exceed
25% of the offering.

A - A total of 4,800 shares was purchased by funds in the Salomon
Brothers complex for an aggregate purchase price of $62,400.
B - A total of 500 shares was purchased by funds in the Salomon
Brothers complex for an aggregate purchase price of $9,500.
C - A total of 4,800 shares was purchased by funds in the Salomon
Brothers complex for an aggregate purchase price of $76,800.
D - A total of 4,700 shares was purchased by funds in the Salomon
Brothers complex for an aggregate purchase price of $75,200.
E - A total of 9,200 shares was purchased by funds in the Salomon
Brothers complex for an aggregate purchase price of $147,200.
F - A total of 260,600 shares was purchased by funds in the Salomon
Brothers complex for an aggregate purchase price of $2,866,600.
G - A total of 3,700 shares was purchased by funds in the Salomon
Brothers complex for an aggregate purchase price of $79,550.
H - A total of 2,700 shares was purchased by funds in the Salomon
Brothers complex for an aggregate purchase price of $41,850.
# C_2018380EN.01000101.xml

| 22.10.2018 | EN | Official Journal of the European Union | C 380/1 |
| --- | --- | --- | --- |

22.10.2018

EN

Official Journal of the European Union

C 380/1

---

Non-opposition to a notified concentration

(Case M.9104 — Bain Capital Private Equity/Esure Group)

(Text with EEA relevance)

(2018/C 380/01)

On 12 October 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9104. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9104. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
SMITH BARNEY INVESTMENT TRUST
on behalf of
SMITH BARNEY S&P 500 INDEX FUND
(the "Fund")

Supplement dated February 5, 1998
to
Prospectus dated December 30, 1997



For Nebraska Investors:


	CLASS D SHARES OF THE FUND ARE NOT AVAILABLE 
FOR PURCHASE BY RESIDENTS OF NEBRASKA.






FD 01395     2/98


u:legal\funds\\slit\misc\500stk.doc
[Federal Register Volume 87, Number 116 (Thursday, June 16, 2022)]
[Notices]
[Pages 36337-36338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-12952]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Development of microbiome-related 
approaches for diagnosis/mitigation/treatment of radiation injuries 
(U01 clinical trial not allowed).
    Date: July 11-12, 2022.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G41, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Kelly L. Hudspeth, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G41 
Rockville, MD 20852, 240-669-5067, <a href="/cdn-cgi/l/email-protection#8de6e8e1e1f4a3e5f8e9fefde8f9e5cde3e4e5a3eae2fb"><span class="__cf_email__" data-cfemail="264d434a4a5f084e5342555643524e66484f4e08414950">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


[[Page 36338]]


    Dated: June 10, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-12952 Filed 6-15-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350 ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002





In
connection with the Report of Earth Biofuels, Inc., a Delaware corporation, (the
“Company”) on Form 10-QSB for the quarter ended September 30, 2008, as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Dennis G. McLaughlin, III, Chief Executive Officer of the Company, certify
the following pursuant to Section 18, U.S.C. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002:





1.
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





2.
            The
      information contained in the report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.








/s/ Dennis G. McLaughlin,
III


By:
Dennis G. McLaughlin, III


Its:  Chief
Executive Officer





November
19, 2008
Exhibit 32.1

                        CERTIFICATION OF PERIODIC REPORT

Pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley  Act of  2002,  each  of the  undersigned  officers  of  Veridium
Corporation (the "Company"), certifies that:

     1.   The  Quarterly  Report  on Form  10-QSB of the  Company  for the three
          months ended March 31, 2004 (the  "Report")  fully  complies  with the
          requirements of Section 13(a) or 15(d) of the Securities  Exchange Act
          of 1934 (15 U.S.C. 78m or 78o(d)); and

     2.   The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.




VERIDIUM CORPORATION


               /S/      JAMES F. GREEN
               -----------------------
By:                     JAMES F. GREEN
                        Chief Executive Officer
Date:                   May 12, 2005


               /S/      MICHAEL DESROSIERS
               ---------------------------
By:                     MICHAEL DESROSIERS
                        Chief Financial Officer
Date:                   May 12, 2005


This  certification  is made solely for the purpose of 18 U.S.C.  Section  1350,
subject  to the  knowledge  standard  contained  therein,  and not for any other
purpose.
```
 
 
CRUDE OIL, LIGHT SWEET-WTI - ICE FUTURES EUROPE                      Code-067411
FUTURES ONLY POSITIONS AS OF 09/16/14                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(CONTRACTS OF 1,000 BARRELS)                         OPEN INTEREST:      465,780
COMMITMENTS
  95,308   28,290  125,800  223,865  296,538  444,973  450,628   20,807   15,152

CHANGES FROM 09/09/14 (CHANGE IN OPEN INTEREST:      1,723)
   8,529     -913    2,688  -13,130   -2,844   -1,913   -1,069    3,636    2,792

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    20.5      6.1     27.0     48.1     63.7     95.5     96.7      4.5      3.3

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      136)
      39       28       59       60       56      126      122
```

----

Updated September 19, 2014
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

CLEVEN LEWIS ROBERSON, 

Plaintiff-Appellant,

v.  No. 00-1880

KENNETH S. APFEL, Commissioner of

Social Security Administration,

Defendant-Appellee. 

Appeal from the United States District Court

for the District of Maryland, at Baltimore.

Marvin J. Garbis, District Judge.

(CA-99-3544-MJG)

Submitted: October 26, 2000

Decided: November 6, 2000

Before WIDENER, MICHAEL, and KING, Circuit Judges.

Affirmed by unpublished per curiam opinion. 

COUNSEL

Cleven Lewis Roberson, Appellant Pro Se. Lynne Ann Battaglia,

United States Attorney, Allen F. Loucks, OFFICE OF THE UNITED

STATES ATTORNEY, Baltimore, Maryland, for Appellee.

Unpublished opinions are not binding precedent in this circuit. See

Local Rule 36(c). 
OPINION

PER CURIAM: 

Cleven Lewis Roberson appeals the district court’s dismissal without prejudice of his petition for judicial review of the denial of disability benefits. We affirm. 

Roberson applied to the Social Security Administration ("SSA")

for disability benefits. After an administrative law judge denied relief,

Roberson sought review by the SSA’s Appeals Council. After waiting

seven months for a decision by the Council, Roberson filed for judicial review. The district court dismissed, ruling it could not review an

SSA action without a final decision by the Appeals Council. This

decision was correct. See Sims v. Apfel, 120 S. Ct. 2080, 2083 (2000).

In addition to challenging the denial of benefits, Roberson asserts

on appeal that the district court and the SSA attorneys conducted

themselves improperly. He cites only one example of such alleged

impropriety: the district court’s allowing the SSA sixty rather than

twenty days to answer Roberson’s complaint. In fact, Fed. R. Civ. P.

12(a)(3) establishes a sixty-day deadline for federal agencies to file

answers. Thus, we find no support for Roberson’s allegations of

impropriety. 

Accordingly, we affirm the judgment of the district court. Furthermore, we deny Roberson’s motions for "enforcement of an agency

order" and for default judgment. We dispense with oral argument

because the facts and legal contentions are adequately presented in the

materials before the court and argument would not aid the decisional

process. 

AFFIRMED

2 ROBERSON v. APFEL
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 74 Introduced in House (IH)]

113th CONGRESS
  2d Session
H. CON. RES. 74

       Providing for a correction in the enrollment of H.R. 3547.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 13, 2014

 Mr. Rogers of Kentucky submitted the following concurrent resolution; 
which was referred to the Committee on Appropriations, and in addition 
     to the Committee on House Administration, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                         CONCURRENT RESOLUTION

 
       Providing for a correction in the enrollment of H.R. 3547.

    Resolved by the House of Representatives (the Senate concurring), 
That in the enrollment of the bill H.R. 3547, the Clerk of the House of 
Representatives shall amend the long title so as to read: ``Making 
consolidated appropriations for the fiscal year ending September 30, 
2014, and for other purposes.''.
                                 <all>
```
# C_2018335EN.01001701.xml

| 20.9.2018 | EN | Official Journal of the European Union | C 335/17 |
| --- | --- | --- | --- |

20.9.2018

EN

Official Journal of the European Union

C 335/17

---

Special Report No 20/2018

‘The African Peace and Security Architecture: need to refocus EU support’

(2018/C 335/09)

The European Court of Auditors hereby informs you that Special Report No 20/2018 ‘The African Peace and Security Architecture: need to refocus EU support’ has just been published.

The report can be accessed for consultation or downloading on the European Court of Auditors' website: http://eca.europa.eu

---
Jambulat TKHILAISHVILI, Petitioner, v. UNITED STATES.

No. 19-5853

Supreme Court of the United States.

October 15, 2019

Petition for writ of certiorari to the United States Court of Appeals for the First Circuit denied.
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 116 Introduced in House (IH)]

113th CONGRESS
  2d Session
H. J. RES. 116

 Providing for the approval of the Congress of the proposed Agreement 
for Cooperation Between the Government of the United States of America 
  and the Government of the Socialist Republic of Vietnam Concerning 
      Peaceful Uses of Nuclear Energy transmitted on May 8, 2014.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              June 9, 2014

 Mr. Kinzinger of Illinois (for himself and Mr. Engel) introduced the 
  following joint resolution; which was referred to the Committee on 
                            Foreign Affairs

_______________________________________________________________________

                            JOINT RESOLUTION

 
 Providing for the approval of the Congress of the proposed Agreement 
for Cooperation Between the Government of the United States of America 
  and the Government of the Socialist Republic of Vietnam Concerning 
      Peaceful Uses of Nuclear Energy transmitted on May 8, 2014.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That the Congress does favor 
the proposed agreement for cooperation transmitted to the Congress by 
the President on May 8, 2014.
                                 <all>
```
Exhibit 32.2
 CERTIFICATION OF PERIODIC
REPORT
 I,
Darren L. Miles, Chief Financial Officer of Earth Biofuels, Inc. (the
“Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, 18 U.S.C. Section 1350, that, to the best of my
knowledge:
 (1) the
Quarterly Report on Form 10-Q of the Company for the three months ended March
31, 2008 (the “Report”) fully complies with the requirements of Section 13
(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or
78o(d)); and
 (2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 Date: May
20, 2008
 /s/
      Darren L. MilesDarren
      L. MilesChief
      Financial Officer
 A
signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
----

Order of the Court of First Instance of 27 September 2006 — Drazdansky v OHIM — Bad Heilbrunner Naturheilmittel (VITACAN)

(Case T-383/04) (1)

(2006/C 281/78)

Language of the case: German

The President of the First Chamber has ordered that the case be removed from the register.

----

(1)OJ C 314, 18.12.2004.

----
```
 
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 11/04/14          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      354,875
COMMITMENTS
 104,545  102,217  113,597  115,400  108,473  333,542  324,287   21,333   30,588

CHANGES FROM 10/28/14 (CHANGE IN OPEN INTEREST:       -720)
  -2,103   -3,362      981     -240   -5,959   -1,362   -8,340      642    7,620

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    29.5     28.8     32.0     32.5     30.6     94.0     91.4      6.0      8.6

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      183)
      46       74       84       39       40      144      155
```

----

Updated November 7, 2014
John R. COLLINS, Petitioner, v. Tim SHOOP, Warden.

No. 19-5321

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
Robert HILL, Petitioner v. Kate MARTIN, et al.

No. 19-5511

Supreme Court of the United States.

October 15, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
REPUBLIC OF SUDAN, et al., Petitioners, v. James OWENS, et al.

No. 17-1236.

Supreme Court of the United States.

May 26, 2020

Motion of Former U.S. Ambassadors for leave to file a brief as *amici curiae* granted.

*2820Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied. Justice Kavanaugh took no part in the consideration or decision of this motion and this petition.
# C_2018400EN.01000101.xml

| 6.11.2018 | EN | Official Journal of the European Union | C 400/1 |
| --- | --- | --- | --- |

6.11.2018

EN

Official Journal of the European Union

C 400/1

---

Non-opposition to a notified concentration

(Case M.9105 — Rhône Capital/Maxam)

(Text with EEA relevance)

(2018/C 400/01)

On 26 October 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9105. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9105. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---